HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adhesion molecules as prognostic factors in nasopharyngeal carcinoma.

AbstractOBJECTIVE/HYPOTHESIS:
To identify the significance of molecular markers in determining the risk of recurrence and distant metastases in nasopharyngeal carcinoma.
STUDY DESIGN:
In this retrospective case study, we evaluated archival nasopharyngeal carcinoma specimens for patterns of expression of E-cadherin, beta-catenin, c-erb-B2, and Ki-67, which have been demonstrated to be important in other tumors.
METHODS:
Fifty-four cases of nasopharyngeal carcinoma were identified, with a maximum follow-up of 13 years. The histopathological sections were stained using an automated immunohistochemical stainer (NexES, Ventana Medical Systems, Tucson, AZ) for E-cadherin (Zymed Laboratories [San Francisco, CA] and Transduction Laboratories [Lexington, KY] clones), beta-catenin (Zymed), c-erb-B2 (Ventana Medical Systems), and Ki-67 (Novocastra, Burlingame, CA). The numbers of positively staining cells were scored as follows: 0%, 1% to 33%, 34% to 66%, or greater than 67%.
RESULTS:
E-cadherin (Zymed) stained positively in only one case. The Transduction Laboratories clone demonstrated a spectrum of staining in all cases, from complete to disrupted to no identifiable membranous staining. The staining was consistently absent at the advancing tumor border, regardless of stage. The loss of beta-catenin expression did not correlate with that of E-cadherin or with clinical outcomes. No staining was identified for c-erb-B2. Ki-67 staining was variable and did not correlate with clinical outcomes.
CONCLUSIONS:
Altered expression or loss of E-cadherin, or both, may result in loss of function, particularly at the infiltrating edge, with resultant loss of cell polarity, cell migration, and eventual metastasis. The interpretation of E-cadherin staining depends on antibody source. In contrast to recent studies, beta-catenin expression is not altered and c-erb-B2 expression not identified, suggesting that these markers are not important in the prognosis of nasopharyngeal carcinoma.
AuthorsY Shnayder, M A Kuriakose, H Yee, F A Chen, M D DeLacure, X N Xue, J Jagirdar
JournalThe Laryngoscope (Laryngoscope) Vol. 111 Issue 10 Pg. 1842-6 (Oct 2001) ISSN: 0023-852X [Print] United States
PMID11801955 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • CTNNB1 protein, human
  • Cadherins
  • Cell Adhesion Molecules
  • Cytoskeletal Proteins
  • Ki-67 Antigen
  • Trans-Activators
  • beta Catenin
  • Receptor, ErbB-2
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (analysis)
  • Cadherins (analysis)
  • Carcinoma, Squamous Cell (pathology)
  • Cell Adhesion Molecules (analysis)
  • Cytoskeletal Proteins (analysis)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Ki-67 Antigen (analysis)
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms (pathology)
  • Nasopharynx (pathology)
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local (pathology)
  • Neoplasm Staging
  • Receptor, ErbB-2 (analysis)
  • Retrospective Studies
  • Trans-Activators
  • beta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: